DDX53 and colorectal carcinoma: To evaluate the predictive value of CRC-specific MDSC, this was further confirmed in vivo, in which CT26-bearing mice were treated with Nor-NOHA or the specific iNOS inhibitor, 1400W, as the only treatment.